Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn’s disease
- 1 August 2018
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 30 (8) , 861-867
Abstract
Background: Mucosal healing is an established treatment endpoint in Crohn’s disease (CD). Still, clinical indices and inflammatory markers are used widely in CD surveillance. Aim: The aim of this study was to investigate the diagnostic performance as well as the relationship of C-reactive protein (CRP) and Crohn’s Disease Activity Index (CDAI) with small bowel capsule endoscopy’s (SBCE) inflammation scoring index, the Lewis Score (LS). Patients and methods: CDAI, CRP, and SBCE findings of 30 CD patients with isolated small bowel disease were retrieved from our academic institution patient records and were analyzed statistically. Results: SBCE showed significant mucosal inflammation [mean (SD) LS: 1599 (1380)], in nine (60.0%) of 15 patients who were in both clinical and biochemical remission. CDAI and CRP showed a weak and moderate correlation with LS (r=0.317, P=0.088 and r=0.516, P=0.004, respectively). The diagnostic performance of CDAI and CRP in predicting mucosal inflammation was as follows: sensitivity 23.8 and 52.4%; specificity 100 and 66.7%; positive predictive value 100 and 78.6%; and negative predictive value 36.0 and 37.5%. The area under the curve toward endoscopic activity prediction was 0.70 and 0.69, respectively. Conclusion: Both CDAI and CRP underestimated endoscopic activity as expressed by the LS in a significant proportion of patients with quiescent disease.Keywords
This publication has 43 references indexed in Scilit:
- Factors affecting outcomes in Crohn's disease over 15 yearsGut, 2012
- Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based CohortGastroenterology, 2010
- Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's DiseaseBMC Gastroenterology, 2009
- Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory changeAlimentary Pharmacology & Therapeutics, 2007
- Diagnostic Value of C-Reactive Protein for Predicting Activity Level of Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2006
- Enteric infection in relapse of inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology, 2004
- Ruling a diagnosis in or out with “SpPIn” and “SnNOut”: a note of cautionBMJ, 2004
- Crohn's disease: monitoring disease activityAlimentary Pharmacology & Therapeutics, 2003
- Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.Gut, 1994
- Serum levels of C‐reactive protein in Crohn's disease and ulcerative colitisEuropean Journal of Clinical Investigation, 1982